Home Drug Codes J Codes J2562 · MOZOBIL
Updated July 1st, 2026

MOZOBIL J Code: J2562

Injection, plerixafor, 1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J2562, effective October 1, 2026: $42.943 per HCPCS billing unit, up 50.7% from $28.489. From CMS's final file.

?
Medicare Payment Limit ?
$28.489
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$28.489
/ HCPCS billing unit · APC 9252
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
9
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, plerixafor, 1 mg
HCPCS Added Date January 1, 2010
Manufacturer Multiple Manufacturers
Route of Administration Subcutaneous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose
Dosage Form Injection | Injection, Solution | Solution

About MOZOBIL

Mozobil is a medication aligned to the HCPCS J Code: J2562 for billing, pricing, and reimbursement purposes in the United States. This Oncology Colony Stimulating Factor medication is administered via the subcutaneous route and manufactured by multiple companies.

According to CMS Drug Use Information: Plerixafor is used by patients with certain types of cancer (non-Hodgkin's lymphoma-NHL, multiple myeloma-MM) to prepare them for stem cell transplant. Stem cells, which are found mainly in the bone marrow, turn into red blood cells, white blood cells, and platelets. Plerixafor is used to help stem cells move from the bone marrow to the bloodstream so that the cells can be collected and stored. The stem cells are then infused back into the patient after chemotherapy or radiation.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 9 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00024-5862-01 Mozobil Sanofi-Aventis U.S. LLC 24 24 MG / 1.2 ML
25021-0416-01 Plerixafor Sagent Pharmaceuticals 24 24 MG / 1.2 ML
43598-0308-23 Plerixafor Dr. Reddy's Laboratories Inc 24 24 MG / 1.2 ML
55150-0356-01 Plerixafor Eugia Us Llc 24 24 MG / 1.2 ML
65219-0284-12 Plerixafor Fresenius Kabi Usa, LLC 24 24 MG / 1.2 ML
•••••-••••-•• Log in to view MOZOBIL
MOZOBIL
MOZOBIL
Login to view 4 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

MOZOBIL Pricing & Reimbursement

J2562 Private Payer Reimbursement
$30.27 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

MOZOBIL CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular
JW / JZ modifiers apply

CMS has identified Mozobil (J2562) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

MOZOBIL Medically Unlikely Edits (MUE)

The most billing units of J2562 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient
48 units / day
= 48 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

MOZOBIL Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Multiple Myeloma Non-Hodgkin's Lymphoma
Drug Class
Hematopoietic Stem Cell Mobilizer [EPC]Increased Hematopoietic Stem Cell Mobilization [PE]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Mozobil billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for MOZOBIL.
Are there any available Mozobil patient assistance programs?
Our team has not identified a manufacturer-published source of patient assistance information for MOZOBIL.
Where can I find Mozobil prescribing information?
MOZOBIL prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →
Where can I find Mozobil side effect information?
Our team has not yet identified a source of side effects information for MOZOBIL. Please check back in a few weeks.
Does billing MOZOBIL require JZ/JW wastage modifiers?
CMS has identified MOZOBIL(J2562) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.